< Back to previous page

Publication

Response to olaparib monotherapy in relapsed ovarian cancer by HRR gene mutational status and HRD scarring analysis: Results from the randomized phase II CLIO trial

Journal Contribution - Journal Article Conference Contribution

Journal: ANNALS OF ONCOLOGY

ISSN: 0923-7534

Volume: 31

Pages: S617 - S618

Publication year:2020

WoS Id: 000573469101105
DOI: https://doi.org/10.1016/j.annonc.2020.08.956
Institutional Repository URL: https://lirias.kuleuven.be/3247548